Combined assessment of ERO1A expression and CD163+ tumor-associated macrophage infiltration is superior to traditional assessment methods in predicting clear cell renal cell carcinoma prognosis
Compared with currently available biomarkers, the combination of ERO1A expression and the density of infiltrating CD163<sup>+</sup> TAMs with TNM stage or the SSIGN score exhibits greater accuracy in evaluating ccRCC patient survival.
Authors
- Mierxiati Abudurexiti (ORCID: https://orcid.org/0000-0002-5909-6663)
- Changjie Ren
- Huaye Wu (ORCID: https://orcid.org/0000-0002-8000-5789)
- Hao Xiang (ORCID: https://orcid.org/0000-0003-4803-3314)
- Tianyu Hong
- Y. C. Yu
- Zhong Wang
- Chao Wang
Institutions
- University of Shanghai for Science and Technology (CN)
- Second Military Medical University (CN)
- Chengdu Women's and Children's Central Hospital (CN)
- Changhai Hospital (CN)
- First People’s Hospital of Zunyi (CN)
- Shanghai Pudong New Area Gongli Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-02-23
- DOI
- https://doi.org/10.3389/fonc.2026.1732415
- Primary Topic
- Immune cells in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00